Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 44, Issue 4 (Apr 2006)

Issues

Release of anandamide from blood cells

Michael Vogeser / Daniela Hauer / Shahnaz Christina Azad / Erasmus Huber / Martin Storr / Gustav Schelling
Published Online: 2006-04-07 | DOI: https://doi.org/10.1515/CCLM.2006.065

Abstract

Background: Endogenous ligands of cannabinoid receptors (endocannabinoids), in particular anandamide (arachidonylethanolamide), have been recognized as being of crucial importance in a variety of physiological functions. Plasma concentrations of anandamide have been measured in a number of investigations; however, discrepant data on “normal” anandamide plasma concentrations were reported. Since this might be caused by pre-analytical variables, we investigated the impact of different sample handling conditions on measured plasma anandamide concentrations.

Methods: Blood samples were taken from healthy volunteers in EDTA- or heparin-containing tubes; whole blood samples were kept at +4°C, room temperature, or 37°C, respectively, for up to 120min before obtaining plasma by centrifugation. Plasma anandamide concentrations were measured by an isotope-dilution liquid chromatography tandem mass spectrometry (LC-MS/MS) method.

Results: A marked time- and temperature-dependent increase in plasma anandamide concentrations ex vivo was observed in both EDTA- and heparin-containing tubes. Mean anandamide concentrations approximately doubled when EDTA samples were kept at 4°C for 60min before centrifugation [immediately centrifuged, 1.3μg/L (SD 0.3μg/L); 2.8μg/L (SD 0.5μg/L) after storage for 60min; n=12). After storage of heparinized whole-blood samples for 120min at 37°C, a mean plasma anandamide concentration of 11.9μg/L (SD 1.8μg/L) was found. In cell-free plasma, no increase in anandamide concentrations was found.

Conclusion: Anandamide is released from blood cells ex vivo at a very high rate; therefore, strictly standardized pre-analytical protocols have to be applied for plasma anandamide determination.

Keywords: anandamide (arachidonylethanolamide); liquid chromatography-tandem mass spectrometry; preanalytical period

References

  • 1.

    Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346:561–4.Google Scholar

  • 2.

    Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365:61–5.Google Scholar

  • 3.

    Di Marzo , De Petrocellis VL, Fezza F, Ligresti A, Bisogno T. Anandamide receptors. Prostaglandins Leukot Essent Fatty Acids 2002; 66:377–91.Google Scholar

  • 4.

    Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258:1946–9.Google Scholar

  • 5.

    Di Marzo V, Deutsch DG. Biochemistry of the endogenous ligands of cannabinoid receptors. Neurobiol Dis 1998; 5:386–404.CrossrefGoogle Scholar

  • 6.

    Sugiura T, Waku K. Cannabinoid receptors and their endogenous ligands. J Biochem 2002; 132:7–12.Google Scholar

  • 7.

    Pertwee RG, Ross RA. Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 2002; 66:101–21.Google Scholar

  • 8.

    Freund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003; 83:1017–66.Google Scholar

  • 9.

    Walker JM, Huang SM. Endocannabinoids in pain modulation. Prostaglandins Leukot Essent Fatty Acids 2002; 66:235–42.Google Scholar

  • 10.

    Chiang KP, Gerber AL, Sipe JC, Cravatt BF. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum Mol Genet 2004; 13:2113–9.CrossrefGoogle Scholar

  • 11.

    Di Marzo V, Matias I. Endocannabinoid control of food intake and energy balance. Nat Neurosci 2005; 8:585–9.CrossrefGoogle Scholar

  • 12.

    Despres JP, Golay A, Sjostrom L, Rimonabant in Obesity-Lipids Study Group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 2005; 353:2121–34.Google Scholar

  • 13.

    Klein TW, Lane B, Newton CA, Friedman H. The cannabinoid system and cytokine network. Proc Soc Exp Biol Med 2000; 225:1–8.Google Scholar

  • 14.

    Parolaro D, Massi P, Rubino T, Monti E. Endocannabinoids in the immune system and cancer. Prostaglandins Leukot Essent Fatty Acids 2002; 66:319–32.Google Scholar

  • 15.

    Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, et al. The cannabinoid system and immune modulation. J Leukoc Biol 2003; 74:486–96.CrossrefGoogle Scholar

  • 16.

    Maccarrone M, Finazzi-Agro A. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ 2003; 10:946–55.CrossrefGoogle Scholar

  • 17.

    Yamaji K, Sarker KP, Kawahara K, Iino S, Yamakuchi M, Abeyama K, et al. Anandamide induces apoptosis in human endothelial cells: its regulation system and clinical implications. Thromb Haemost 2003; 89:875–84.Google Scholar

  • 18.

    Randall MD, Kendall DA. Endocannabinoids: a new class of vasoactive substances. Trends Pharmacol Sci 1998; 19:55–8.CrossrefGoogle Scholar

  • 19.

    Wagner JA, Hu K, Bauersachs J, Karcher J, Wiesler M, Goparaju SK, et al. Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. J Am Coll Cardiol 2001; 38:2048–54.Google Scholar

  • 20.

    Wagner JA, Jarai Z, Batkai S, Kunos G. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. Eur J Pharmacol 2001; 423:203–10.Google Scholar

  • 21.

    Sipe JC, Arbour N, Gerber A, Beutler E. Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. J Leukoc Biol 2005; 78:231–8.Google Scholar

  • 22.

    Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 1996; 384:83–7.Google Scholar

  • 23.

    Cravatt BF, Lichtman AH. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr Opin Chem Biol 2003; 7:469–75.CrossrefGoogle Scholar

  • 24.

    De Marchi N, De Petrocellis L, Orlando P, Daniele F, Fezza F, Di Marzo V. Endocannabinoid signalling in the blood of patients with schizophrenia. Lipids Health Dis 2003; 2:5.CrossrefGoogle Scholar

  • 25.

    Obata T, Sakurai Y, Kase Y, Tanifuji Y, Horiguchi T. Simultaneous determination of endocannabinoids (arachidonylethanolamide and 2-arachidonylglycerol) and isoprostane (8-epiprostaglandin F2alpha) by gas chromatography-mass spectrometry-selected ion monitoring for medical samples. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 792:131–40.Google Scholar

  • 26.

    Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A. Exercise activates the endocannabinoid system. Neuroreport 2003; 14:2209–11.CrossrefGoogle Scholar

  • 27.

    Fernandez-Rodriguez CM, Romero J, Petros TJ, Bradshaw H, Gasalla JM, Gutierrez ML, et al. Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis. Liver Int 2004; 24:477–83.CrossrefGoogle Scholar

  • 28.

    Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J, et al. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology 2004; 29:2108–14.CrossrefGoogle Scholar

  • 29.

    Habayeb OM, Taylor AH, Evans MD, Cooke MS, Taylor DJ, Bell SC, et al. Plasma levels of the endocannabinoid anandamide in women – a potential role in pregnancy maintenance and labor? J Clin Endocrinol Metab 2004; 89:5482–7.Google Scholar

  • 30.

    Bisogno T, Maurelli S, Melck D, De Petrocellis L, Di Marzo V. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J Biol Chem 1997; 272:3315–23.Google Scholar

  • 31.

    Giuffrida AF, Piomelli D. Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. FEBS Lett 1998; 422:373–6.Google Scholar

About the article

Corresponding author: PD Dr. med. Michael Vogeser, Institute of Clinical Chemistry, Hospital of the University of Munich, Marchioninistr. 15, 81377 Munich, Germany Phone: +49-89-70953221, Fax: +49-89-70953240


Received: 2005-09-05

Accepted: 2006-01-03

Published Online: 2006-04-07

Published in Print: 2006-04-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2006.065.

Export Citation

©2006 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
A.H. Taylor, C. Ang, S.C. Bell, and J.C. Konje
Human Reproduction Update, 2007, Volume 13, Number 5, Page 501
[3]
Flaminia Fanelli, Valentina D. Di Lallo, Ilaria Belluomo, Rosaria De Iasio, Margherita Baccini, Elena Casadio, Daniela Ibarra Gasparini, Michelangelo Colavita, Alessandra Gambineri, Gabriele Grossi, Valentina Vicennati, Renato Pasquali, and Uberto Pagotto
Journal of Lipid Research, 2012, Volume 53, Number 3, Page 481
[4]
Daniela Hauer, Gustav Schelling, Hannah Gola, Patrizia Campolongo, Julia Morath, Benno Roozendaal, Gilava Hamuni, Alexander Karabatsiakis, Piray Atsak, Michael Vogeser, Iris-Tatjana Kolassa, and Katharina Domschke
PLoS ONE, 2013, Volume 8, Number 5, Page e62741
[5]
Alexander Choukèr, Ines Kaufmann, Simone Kreth, Daniela Hauer, Matthias Feuerecker, Detlef Thieme, Michael Vogeser, Manfred Thiel, Gustav Schelling, and Alejandro Lucia
PLoS ONE, 2010, Volume 5, Number 5, Page e10752
[6]
Hannah L. Pellkofer, Joachim Havla, Daniela Hauer, Gustav Schelling, Shahnaz C. Azad, Tania Kuempfel, Walter Magerl, Volker Huge, and Louis S. Premkumar
PLoS ONE, 2013, Volume 8, Number 8, Page e71500
[7]
Buqing Yi, Igor Nichiporuk, Michel Nicolas, Stefan Schneider, Matthias Feuerecker, Galina Vassilieva, Detlef Thieme, Gustav Schelling, and Alexander Choukèr
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2016, Volume 67, Page 92
[8]
M. Bluher, S. Engeli, N. Kloting, J. Berndt, M. Fasshauer, S. Batkai, P. Pacher, M. R. Schon, J. Jordan, and M. Stumvoll
Diabetes, 2006, Volume 55, Number 11, Page 3053
[9]
A. J. Sánchez López, L. Román-Vega, E. Ramil Tojeiro, A. Giuffrida, and A. García-Merino
Clinical & Experimental Immunology, 2015, Volume 179, Number 1, Page 119
[10]
Rodolfo Gómez, Javier Conde, Morena Scotece, Verónica López, Francisca Lago, Juan Jesús Gómez Reino, and Oreste Gualillo
Journal of Orthopaedic Research, 2014, Volume 32, Number 9, Page 1137
[11]
C. Rapino, N. Battista, M. Bari, and M. Maccarrone
Human Reproduction Update, 2014, Volume 20, Number 4, Page 501
[12]
Ulrike Thieme, Gustav Schelling, Daniela Hauer, Robert Greif, Torsten Dame, Ruediger Paul Laubender, Werner Bernhard, Detlef Thieme, Patrizia Campolongo, and Lorenz Theiler
Drug Testing and Analysis, 2014, Volume 6, Number 1-2, Page 17
[13]
Michiel G.J. Balvers, Heleen M. Wortelboer, Renger F. Witkamp, and Kitty C.M. Verhoeckx
Analytical Biochemistry, 2013, Volume 434, Number 2, Page 275
[14]
Carina Jarzimski, Matthias Karst, Alexander A. Zoerner, Christin Rakers, Marcus May, Maria T. Suchy, Dimitrios Tsikas, Joachim K. Krauss, Dirk Scheinichen, Jens Jordan, and Stefan Engeli
British Journal of Clinical Pharmacology, 2012, Volume 74, Number 1, Page 54
[15]
Timothy H. Marczylo, Patricia M.W. Lam, Akwasi A. Amoako, and Justin C. Konje
Analytical Biochemistry, 2010, Volume 400, Number 2, Page 155
[16]
Aliye Ozalp and Begona Barroso
Analytical Biochemistry, 2009, Volume 395, Number 1, Page 68
[17]
M. Feuerecker, D. Hauer, T. Gresset, S. Lassas, I. Kaufmann, M. Vogeser, J. Briegel, C. Hornuss, A. Chouker, and G. Schelling
Alcohol and Alcoholism, 2012, Volume 47, Number 3, Page 226
[18]
P. Atsak, D. Hauer, P. Campolongo, G. Schelling, J. L. McGaugh, and B. Roozendaal
Proceedings of the National Academy of Sciences, 2012, Volume 109, Number 9, Page 3504
[20]
M. Feuerecker, D. Hauer, R. Toth, F. Demetz, J. Hölzl, M. Thiel, I. Kaufmann, G. Schelling, and A. Choukèr
European Journal of Applied Physiology, 2012, Volume 112, Number 7, Page 2777
[21]
Alexander A. Zoerner, Frank-Mathias Gutzki, Sandor Batkai, Marcus May, Christin Rakers, Stefan Engeli, Jens Jordan, and Dimitrios Tsikas
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2011, Volume 1811, Number 11, Page 706
[23]
Ines Kaufmann, Gustav Schelling, Christoph Eisner, Hans Peter Richter, Till Krauseneck, Michael Vogeser, Daniela Hauer, Patrizia Campolongo, Alexander Chouker, Antje Beyer, and Manfred Thiel
Psychoneuroendocrinology, 2008, Volume 33, Number 5, Page 676
[24]
Florian Weis, Andres Beiras-Fernandez, Ralf Sodian, Ingo Kaczmarek, Bruno Reichart, Andres Beiras, Gustav Schelling, and Simone Kreth
Journal of Molecular and Cellular Cardiology, 2010, Volume 48, Number 6, Page 1187
[25]
Alexander A. Zoerner, Frank M. Gutzki, Maria T. Suchy, Bibiana Beckmann, Stefan Engeli, Jens Jordan, and Dimitrios Tsikas
Journal of Chromatography B, 2009, Volume 877, Number 26, Page 2909
[26]
Wenying Jian, Richard Edom, Naidong Weng, Peter Zannikos, Zhiming Zhang, and Hao Wang
Journal of Chromatography B, 2010, Volume 878, Number 20, Page 1687
[27]
Michael Vogeser and Gustav Schelling
Clinical Chemical Laboratory Medicine, 2007, Volume 45, Number 8
[28]
JodiAnne T. Wood, John S. Williams, Lakshmipathi Pandarinathan, Amber Courville, Melissa R. Keplinger, David R. Janero, Paul Vouros, Alexandros Makriyannis, and Carol J. Lammi-Keefe
Clinical Chemistry and Laboratory Medicine, 2008, Volume 46, Number 9
[29]
M D Randall
British Journal of Pharmacology, 2009, Volume 152, Number 5, Page 671
[30]
F. Weis, A. Beiras-Fernandez, D. Hauer, C. Hornuss, R. Sodian, S. Kreth, J. Briegel, and G. Schelling
British Journal of Anaesthesia, 2010, Volume 105, Number 2, Page 139
[31]
Cristiana Rossi, Luigi Alberto Pini, Maria Letizia Cupini, Paolo Calabresi, and Paola Sarchielli
European Journal of Clinical Pharmacology, 2008, Volume 64, Number 1, Page 1

Comments (0)

Please log in or register to comment.
Log in